Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion

Overview of attention for article published in Clinical Ophthalmology, April 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,802 followers.

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for #MacularEdema due to branch #RVO | #ECM https://t.co/KviSoYdVYF

16 Apr 2019

Reply Repost Favourite

Ophthopedia Update: Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion https://t.co/PXDtLA6nQQ #Ophthomology #Eye #Ophthotwitter

15 Apr 2019

Reply Repost Favourite

Dove Medical Press

Article Metrics

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion

About this Attention Score

Mentioned by

Readers on